Satellite Symposium - Assessing Fracture Risk: the Future for Designing New Therapies

5 May 2010, Florence, Italy.
The Osteoporotic Virtual Physiological Human (VPHOP) Consortium organizes a symposium entitled "Assessing fracture risk: the future for designing new therapies" which will be held during the IOF WCO-ECCEO10 Congress in Florence, Italy. The symposium will take place in Hall B, Spadolini Pavillion - Fortezza da Basso, Viale Filippo Strozzi 1. The event will provide an opportunity to present the clinical community the early results of the VPHOP project on the new technology to fight osteoprosis.

The symposium program aims to present to the clinical experts the state of the art in technologies to assess the risk of fractures in patients affected by osteoporosis.

Moderators of the symposium will be the VPHOP Project Coordinator, Marco Viceconti and the chair of the VPHOP Clinical Committee, Renè Rizzoli.

The program of the event is the following:

  • 14:00-14:15 Renè Rizzoli (Geneva University Hospital): The role of technology in the fight against osteoporosis
  • 14:15-14:30 Dieter Felsenberg (Charité, Berlin): Clinical prospectives on osteoporosis: bone and muscle
  • 14:30-14:45 Fulvia Taddei (Istituto Ortopedico Rizzoli, Bologna): New technologies to predict the risk of fracture
  • 15:00-15:15 Bert van Rietbergen (Technical University Eindhoven): Tissue level imaging for critical risk assessment
  • 14:45-15:00 Ralph Müller (ETH Zurich): Cell and tissue based simulation of osteoporosis and pharmacological treatment
  • 15:15-15:30 Marco Viceconti (Istituto Ortopedico Rizzoli, Bologna): Personalised, predictive, and integrative medicine: future scenarios for osteoporosis

To attend the satellite symposium you have to be registered to the International Osteoporosis Foundation (IOF) World Congress on Osteoporosis & 10th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis - http://www.iofwco-ecceo10.org
Florence, May 5-8, 2010

For further information, please visit: http://www.vphop.eu

About the Osteoporotic Virtual Physiological Human (VPHOP)
VPHOP is a Collaborative Integrated Project that is developing simulation-based technology to predict the risk of bone fracture in osteoporosis patients. Co-funded by the European Commission as part of the Seventh Framework Program. The project runs for four years starting from September 2008. Coordinated by Rizzoli Orthopaedic Institute, the Project Consortium gathers 19 European Organisations based in Italy, The Netherlands, Germany, Switzerland, Belgium, France, United Kingdom, Sweden, and Iceland.

For more information: http://www.vphop.eu.

Most Popular Now

Researchers Capture First Images of Oxyg…

Oxygen in cancer tumors is known to be a major factor that helps radiation therapy be successful. Hypoxia, or starvation of oxygen, in solid tumors is also thought to be...

VTT Makes New Investments in Digital Hea…

VTT is launching new research activities in the area of digital health as part of the growing wellbeing and health technology ecosystem in Kuopio. The new initiative aims to create...

A New Method of Artificial Intelligence …

Despite the immense progress in the field of AI in recent years, we are still very far from human intelligence. Indeed, if current AI techniques allow to train computer agents...

FDA Informs Health Care Providers, Facil…

Today, the U.S. Food and Drug Administration is issuing a safety communication informing health care providers, facilities and patients about cybersecurity vulnerabilities identified for certain GE Healthcare Clinical Information Central...

eHealthWeek 2020 Croatia - Trusted Infor…

15 - 17 April 2020, Rovinj, Croatia. In its capacity of hosting the upcoming Presidency of the Council of the European Union, the Croatian Ministry of Health is in preparations to...

Siemens Healthineers Presents Solutions …

CT scanners with intelligent user guidance, AI-based software assistants for MRI and a lab system that revolutionizes workflows: Siemens Healthineers is showcasing its products and solutions according to the motto...

NHS IT Chiefs Set the Stage for a Year o…

3 - 4 March 2019, London, United Kingdom. NHS technology leaders are to kick off the second-ever Digital Health Rewired Conference and Exhibition on 3 - 4 March at the Olympia...

PatchAi Startup has Arrived in the Marke…

PatchAi - a startup that offers, thanks to Artificial Intelligence and Machine Learning, an empathic virtual assistant to patients participating in clinical trials - announced that it has closed two...

Digital Health App Medicus AI Earns CE C…

Medicus AI, the Vienna-based health tech company, has received a ​Class I Medical Device CE Mark for its mobile application. The CE certification mark confirms that Medicus AI conforms to...

Refining Breast Cancer Classification by…

Breast cancer progression can vary significantly between patients. Even within the same tumor, different areas may be composed of different types of cells and characterized by different tumor structures. This...

Human Body-on-Chip Platform Enables In V…

Drug development is an extremely arduous and costly process, and failure rates in clinical trials that test new drugs for their safety and efficacy in humans remain very high. According...

FDA Authorizes Marketing of First Cardia…

Today, the U.S. Food and Drug Administration authorized marketing of software to assist medical professionals in the acquisition of cardiac ultrasound, or echocardiography, images. The software, called Caption Guidance, is...